Career jump for Professor Kim Nasmyth
Prof. Kim Nasmyth, Director of the IMP Vienna, Boehringer Ingelheim’s Basic Research Institute, to take up prestigious Oxford Chair.
The Research Institute of Molecular Pathology (IMP) which belongs to the international pharmaceutical company Boehringer Ingelheim has already served as starting point or stepping stone for several internationally outstanding scientific careers. Now a call from one of the best Universities in Europe has reached IMP Director Kim Nasmyth.
In January 2006 he will take over the Whitley Chair of Biochemistry at the University of Oxford from Edwin Southern. One year later he will follow Raymond Dwek as Head of the Department of Biochemistry. He will then lead one of the largest departments of Biochemistry in the western world with approximately 850 employees and students.
The Whitley Chair has an excellent reputation: founded in 1920, the position has been held by a succession of outstanding scientists, including Nobel laureates Hans Krebs and Rodney Porter. “The appointment certainly honours me personally but is also proof of the IMP’s excellent reputation in the scientific world” says Nasmyth.
- Press Release English (pdf, 133 KB)
- Presseaussendung Deutsch (pdf, 111 KB)